Pfizer Inc (PFE)
27.78USD
1 Jul 2013
$-0.23 (-0.82%)
$28.01
$27.97
$28.30
$27.71
67,767,998
62,173,092
$31.15
$22.00
PFE
About
Overall
| Beta: | 0.73 |
| Market Cap (Mil.): | $197,049.80 |
| Shares Outstanding (Mil.): | 7,093.22 |
| Dividend: | 0.24 |
| Yield (%): | 3.46 |
Financials
| PFE | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 19.69 | 32.92 | 33.02 |
| EPS (TTM): | 1.41 | -- | -- |
| ROI: | 6.65 | 19.76 | 19.07 |
| ROE: | 12.71 | 20.57 | 20.00 |
Pfizer, Novartis may join Amgen in bidding for Onyx: sources
NEW YORK - Onyx Pharmaceuticals Inc , whose cancer drugs promise a strong revenue stream, is attracting preliminary buyout interest from several large pharmaceutical companies such as Pfizer Inc and Novartis AG , two people familiar with the matter said on Monday.
Release of Eliquis blood clot preventer story
The blood clot preventer Eliquis, sold by Pfizer Inc and Bristol-Myers Squibb Co, proved as effective as widely used warfarin in treating a dangerous condition known as venous thromboembolism and caused far less bleeding, according to data from a large clinical trial.
Pfizer says shareholders snap up remaining Zoetis shares
- Pfizer Inc on Monday said it would complete the spinoff of its Zoetis Inc animal health business after investors offered to trade their Pfizer shares for the company's remaining majority stake in the unit.
UPDATE 2-Pfizer says shareholders snap up remaining Zoetis shares
June 24 - Pfizer Inc on Monday said it would complete the spinoff of its Zoetis Inc animal health business after investors offered to trade their Pfizer shares for the company's remaining majority stake in the unit.
Pfizer says shareholders snap up remaining Zoetis shares
June 24 - Pfizer Inc said on Monday that enough Pfizer shareholders offered to trade their shares for stock in Pfizer's majority owned Zoetis Inc animal health business to allow Pfizer to complete its spinoff of the unit.
Teva, Sun Pharma to pay $2.15 billion to settle Pfizer patent suit
- Pfizer Inc said Teva Pharmaceuticals Industries Ltd and Sun Pharmaceutical Industries Ltd would pay $2.15 billion to settle a patent suit related to its acid-reflux drug.
UPDATE 2-Teva, Sun Pharma to pay $2.15 bln to settle Pfizer patent suit
* Teva to pay $1.8 bln, half this year and rest by Oct 2014
RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug
CHICAGO, May 23 - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.
Pfizer takes its shot at a vaccine for evasive superbug
CHICAGO - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.
Pfizer to spin off Zoetis stake to shareholders
- Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount.
Competitors
| Price | Change | |
|---|---|---|
| The Procter & Gamble Company (PG.N) | $78.02 | +1.03 |
| Johnson & Johnson (JNJ.N) | $86.63 | +0.77 |
| Novartis AG (NOVN.VX) | CHF67.15 | -0.15 |
| Merck & Co., Inc. (MRK.N) | $46.32 | -0.13 |
| Roche Holding Ltd. (ROG.VX) | CHF234.40 | -0.20 |
| Abbott Laboratories (ABT.N) | $35.03 | +0.15 |
| Bayer AG (BAYGn.DE) | €82.06 | -0.31 |
| Bayer AG (BAYE.F) | -- | -- |
| Sanofi SA (SASY.PA) | €79.56 | -0.31 |
| AstraZeneca plc (AZN.L) | 3,158.74p | +8.00 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$115.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
